Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

SANGAMO THERAPEUTICS, INC. (SGMOQ) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

SANGAMO THERAPEUTICS, INC. (SGMOQ), most recent 12 months reported: revenue $34.56M, net loss $123.33M, free cash flow -$90.46M. Latest balance sheet on file: liquid cash $27.59M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): SUTRO BIOPHARMA, INC. · PRECISION BIOSCIENCES INC · Pelthos Therapeutics Inc. · C4 Therapeutics, Inc. · Voyager Therapeutics, Inc. · Scilex Holding Company · Monte Rosa Therapeutics, Inc. · Metagenomi Therapeutics, Inc.

Stock screener

Watchlist